Literature DB >> 28993957

Hematopoietic Stem Cell Transplantation in ADA2 Deficiency: Early Restoration of ADA2 Enzyme Activity and Disease Relapse upon Drop of Donor Chimerism.

Giorgia Bucciol1,2, Selket Delafontaine3, Heidi Segers4, Xavier Bossuyt5, Michael S Hershfield6, Leen Moens2, Isabelle Meyts7,8.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28993957     DOI： 10.1007/s10875-017-0449-8

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN： 0271-9142            Impact factor:   8.317


× No keyword cloud information.
  11 in total

1.  Cytokines and soluble tumour necrosis factor I receptor levels during pretransplant conditioning in allogeneic stem-cell transplantation.

Authors:  Johnny Andersen; Carsten Heilmann; Niels Jacobsen; Klaus Bendtzen; Klaus Müller
Journal:  Int Immunopharmacol       Date:  2005-01       Impact factor: 4.932

2.  Mutant ADA2 in vasculopathies.

Authors:  Joris van Montfrans; Andrey Zavialov; Qing Zhou
Journal:  N Engl J Med       Date:  2014-07-31       Impact factor: 91.245

3.  Cytokine and chemokine patterns across 100 days after hematopoietic stem cell transplantation in children.

Authors:  Joseph DiCarlo; Rajni Agarwal-Hashmi; Ami Shah; Paul Kim; Laila Craveiro; Renna Killen; Yael Rosenberg-Hasson; Holden Maecker
Journal:  Biol Blood Marrow Transplant       Date:  2013-12-04       Impact factor: 5.742

4.  Refractory Pure Red Cell Aplasia Manifesting as Deficiency of Adenosine Deaminase 2.

Authors:  Hasan Hashem; Rachel Egler; Jignesh Dalal
Journal:  J Pediatr Hematol Oncol       Date:  2017-07       Impact factor: 1.289

5.  Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy.

Authors:  Paulina Navon Elkan; Sarah B Pierce; Reeval Segel; Tom Walsh; Judith Barash; Shai Padeh; Abraham Zlotogorski; Yackov Berkun; Joseph J Press; Masha Mukamel; Isabel Voth; Philip J Hashkes; Liora Harel; Vered Hoffer; Eduard Ling; Fatos Yalcinkaya; Ozgur Kasapcopur; Ming K Lee; Rachel E Klevit; Paul Renbaum; Ariella Weinberg-Shukron; Elif F Sener; Barbara Schormair; Sharon Zeligson; Dina Marek-Yagel; Tim M Strom; Mordechai Shohat; Amihood Singer; Alan Rubinow; Elon Pras; Juliane Winkelmann; Mustafa Tekin; Yair Anikster; Mary-Claire King; Ephrat Levy-Lahad
Journal:  N Engl J Med       Date:  2014-02-19       Impact factor: 91.245

6.  Hematopoietic stem cell transplantation rescues the hematological, immunological, and vascular phenotype in DADA2.

Authors:  Hasan Hashem; Ashish R Kumar; Ingo Müller; Florian Babor; Robbert Bredius; Jignesh Dalal; Amy P Hsu; Steven M Holland; Dennis D Hickstein; Stephen Jolles; Robert Krance; Ghadir Sasa; Mervi Taskinen; Minna Koskenvuo; Janna Saarela; Joris van Montfrans; Keith Wilson; Barbara Bosch; Leen Moens; Michael Hershfield; Isabelle Meyts
Journal:  Blood       Date:  2017-10-03       Impact factor: 22.113

7.  Bortezomib for refractory autoimmunity in pediatrics.

Authors:  Pooja Khandelwal; Stella M Davies; Michael S Grimley; Michael B Jordan; Brian R Curtis; Sonata Jodele; Rebecca Marsh; Alexandra H Filipovich
Journal:  Biol Blood Marrow Transplant       Date:  2014-06-28       Impact factor: 5.742

8.  Extending the Clinical Phenotype of Adenosine Deaminase 2 Deficiency.

Authors:  Tal Ben-Ami; Shoshana Revel-Vilk; Rebecca Brooks; Avraham Shaag; Michael S Hershfield; Susan J Kelly; Nancy J Ganson; Shlomit Kfir-Erenfeld; Michael Weintraub; Orly Elpeleg; Yackov Berkun; Polina Stepensky
Journal:  J Pediatr       Date:  2016-08-08       Impact factor: 4.406

9.  Mutations in CECR1 associated with a neutrophil signature in peripheral blood.

Authors:  Alexandre Belot; Evangeline Wassmer; Marinka Twilt; Jean-Christophe Lega; Leo Ah Zeef; Anthony Oojageer; Paul R Kasher; Anne-Laure Mathieu; Christophe Malcus; Julie Demaret; Nicole Fabien; Sophie Collardeau-Frachon; Laura Mechtouff; Laurent Derex; Thierry Walzer; Gillian I Rice; Isabelle Durieu; Yanick J Crow
Journal:  Pediatr Rheumatol Online J       Date:  2014-09-24       Impact factor: 3.054

10.  Hematopoietic stem cell transplantation rescues the immunologic phenotype and prevents vasculopathy in patients with adenosine deaminase 2 deficiency.

Authors:  Lien Van Eyck; Michael S Hershfield; Diana Pombal; Susan J Kelly; Nancy J Ganson; Leen Moens; Glynis Frans; Heidi Schaballie; Gert De Hertogh; James Dooley; Xavier Bossuyt; Carine Wouters; Adrian Liston; Isabelle Meyts
Journal:  J Allergy Clin Immunol       Date:  2014-11-25       Impact factor: 10.793
View more
  9 in total

1.  A Chinese DADA2 patient: report of two novel mutations and successful HSCT.

Authors:  Luyao Liu; Wenjie Wang; Ying Wang; Jia Hou; Wenjing Ying; Xiaoying Hui; Qinhua Zhou; Danru Liu; Haili Yao; Jinqiao Sun; Xiaochuan Wang
Journal:  Immunogenetics       Date:  2019-01-05       Impact factor: 2.846

Review 2.  Expanding spectrum of DADA2: a review of phenotypes, genetics, pathogenesis and treatment.

Authors:  Benzeeta Pinto; Prateek Deo; Susmita Sharma; Arshi Syal; Aman Sharma
Journal:  Clin Rheumatol       Date:  2021-03-31       Impact factor: 2.980

3.  Warts and DADA2: a Mere Coincidence?

Authors:  Katrijn Arts; Jenna R E Bergerson; Amanda K Ombrello; Morgan Similuk; Andrew J Oler; Anahita Agharahimi; Emily M Mace; Mike Hershfield; Carine Wouters; Lien De Somer; Marie-Anne Morren; Rebeca Perez-de Diego; Leen Moens; Alexandra F Freeman; Isabelle Meyts
Journal:  J Clin Immunol       Date:  2018-11-01       Impact factor: 8.542

Review 4.  Deficiency of Adenosine Deaminase 2 (DADA2): Updates on the Phenotype, Genetics, Pathogenesis, and Treatment.

Authors:  Isabelle Meyts; Ivona Aksentijevich
Journal:  J Clin Immunol       Date:  2018-06-27       Impact factor: 8.317

5.  ALPS-Like Phenotype Caused by ADA2 Deficiency Rescued by Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Federica Barzaghi; Federica Minniti; Margherita Mauro; Massimiliano De Bortoli; Rita Balter; Elisa Bonetti; Ada Zaccaron; Virginia Vitale; Maryam Omrani; Matteo Zoccolillo; Immacolata Brigida; Maria Pia Cicalese; Massimo Degano; Michael S Hershfield; Alessandro Aiuti; Anastasiia V Bondarenko; Matteo Chinello; Simone Cesaro
Journal:  Front Immunol       Date:  2019-01-14       Impact factor: 7.561

Review 6.  Allogeneic Hematopoietic Cell Transplantation for Patients With Deficiency of Adenosine Deaminase 2 (DADA2): Approaches, Obstacles and Special Considerations.

Authors:  Hasan Hashem; Dimana Dimitrova; Isabelle Meyts
Journal:  Front Immunol       Date:  2022-07-07       Impact factor: 8.786

7.  Case Report: Susceptibility to viral infections and secondary hemophagocytic lymphohistiocytosis responsive to intravenous immunoglobulin as primary manifestations of adenosine deaminase 2 deficiency.

Authors:  Enrico Drago; Francesca Garbarino; Sara Signa; Alice Grossi; Francesca Schena; Federica Penco; Elettra Santori; Fabio Candotti; Kaan Boztug; Stefano Volpi; Marco Gattorno; Roberta Caorsi
Journal:  Front Immunol       Date:  2022-09-09       Impact factor: 8.786

Review 8.  The Many Faces of a Monogenic Autoinflammatory Disease: Adenosine Deaminase 2 Deficiency.

Authors:  Jennifer Lee Kendall; Jason Michael Springer
Journal:  Curr Rheumatol Rep       Date:  2020-08-26       Impact factor: 4.592

9.  Hematopoietic Cell Transplantation Cures Adenosine Deaminase 2 Deficiency: Report on 30 Patients.

Authors:  Hasan Hashem; Giorgia Bucciol; Seza Ozen; Sule Unal; Ikbal Ok Bozkaya; Nurten Akarsu; Mervi Taskinen; Minna Koskenvuo; Janna Saarela; Dimana Dimitrova; Dennis D Hickstein; Amy P Hsu; Steven M Holland; Robert Krance; Ghadir Sasa; Ashish R Kumar; Ingo Müller; Monica Abreu de Sousa; Selket Delafontaine; Leen Moens; Florian Babor; Federica Barzaghi; Maria Pia Cicalese; Robbert Bredius; Joris van Montfrans; Valentina Baretta; Simone Cesaro; Polina Stepensky; Neven Benedicte; Despina Moshous; Guillaume Le Guenno; David Boutboul; Jignesh Dalal; Joel P Brooks; Elif Dokmeci; Jasmeen Dara; Carrie L Lucas; Sophie Hambleton; Keith Wilson; Stephen Jolles; Yener Koc; Tayfun Güngör; Caroline Schnider; Fabio Candotti; Sandra Steinmann; Ansgar Schulz; Chip Chambers; Michael Hershfield; Amanda Ombrello; Jennifer A Kanakry; Isabelle Meyts
Journal:  J Clin Immunol       Date:  2021-07-29       Impact factor: 8.542
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.